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Aim
Functional information for appropriate therapy monitoring
of advanced targeted therapies is essential, but standard
follow up (FU) examinations with computed tomography
(CT) still focus on traditional size measurements. Iodine
quantification with dual energy CT (DECT) enables addi-
tional quantitative assessment of contrast media uptake.
Our purpose was to investigate patterns of contrast media
enhancement under BRAF inhibitor therapy (BRAF-I) by
performing histogram analyses (HA) of iodine maps based
on DECT.
Methods
11 stage IV melanoma patients underwent DECT at
baseline and at least one FU. 8 patients were RECIST-
responder to BRAF-I. Volume segmentation of in total
33 metastases was performed semi-automatically. For
each lesion, iodine uptake (IU) and HA of iodine maps
including maximum HU value (max), mean HU value
(mean) and standard deviation (STD) was calculated.
Results
For BRAF-responder mean, max and STD of the iodine
histograms decrease significantly (p<0.05 at FU 2). In
patients with progress, 6 of 7 lesions showed increasing
max and STD, while mean and IU were decreasing
(4 lesions) as well as increasing (3 lesions). Analysis of
the metastasis with mixed response revealed about
stable values for mean, max and STD for the responding
part and increasing values for the viable tumour.
Conclusion
For patients under BRAF-I, HA of iodine maps based on
DECT revealed a typical pattern of contrast media
enhancement. HA has potential to add an objective and
functional criterion to traditional size measurements of
standard CT examinations and can contribute to accurate
response assessment for BRAF-I therapy.
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